These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3908741)

  • 21. Mediation of macrophage effector function by lymphokine.
    Poulter LW; Turk JL
    Agents Actions; 1976 Feb; 6(1-3):127-34. PubMed ID: 7933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The metabolism of glycerophospholipids and its regulation of macrophages].
    Nakagawa Y
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):222-34. PubMed ID: 1902583
    [No Abstract]   [Full Text] [Related]  

  • 23. Different mechanisms of macrophage activation with guinea pig macrophage activation factor, lipopolysaccharide and muramyl dipeptide.
    Onozaki K; Hashimoto T
    Int Arch Allergy Appl Immunol; 1985; 76(4):296-301. PubMed ID: 3884516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migration inhibitory factor.
    Remold HG; Mednis AD
    Methods Enzymol; 1985; 116():379-94. PubMed ID: 3911018
    [No Abstract]   [Full Text] [Related]  

  • 25. Murine T-cell hybridomas that produce lymphokine with macrophage-activating factor activity as a constitutive product.
    Erickson KL; Cicurel L; Gruys E; Fidler IJ
    Cell Immunol; 1982 Sep; 72(1):195-201. PubMed ID: 6184172
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
    Piessens WF; Remold HG; David JR
    J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercellular communication: role of soluble factors in cellular immune responses.
    Klesius PH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1015-21. PubMed ID: 6816771
    [No Abstract]   [Full Text] [Related]  

  • 28. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages.
    Varesio L
    J Immunol; 1984 Jun; 132(6):2683-5. PubMed ID: 6202756
    [No Abstract]   [Full Text] [Related]  

  • 30. The mechanism of action of lymphokines. VII. Modulation of the action of macrophage migration inhibitory factor by antioxidants and drugs affecting thromboxane synthesis.
    Jakubowski A; Pick E
    Immunopharmacology; 1983 Oct; 6(3):215-29. PubMed ID: 6313550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane perturbation and stimulation of arachidonic acid metabolism.
    Gemsa D; Leser HG; Seitz M; Deimann W; Bärlin E
    Mol Immunol; 1982 Oct; 19(10):1287-96. PubMed ID: 6294507
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological control of lymphokine function.
    Yoshida T; Cohen S
    Fed Proc; 1982 Jun; 41(8):2480-3. PubMed ID: 7044831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolipid affinity purification of migration inhibitory factor.
    Liu DY; David JR; Remold HG
    Nature; 1982 Mar; 296(5852):78-80. PubMed ID: 7038511
    [No Abstract]   [Full Text] [Related]  

  • 34. The MAF dilemma.
    Fidler IJ
    Lymphokine Res; 1984; 3(2):51-4. PubMed ID: 6379318
    [No Abstract]   [Full Text] [Related]  

  • 35. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
    Schultz RM; Nanda SK; Altom MG
    J Immunol; 1985 Sep; 135(3):2040-4. PubMed ID: 2991375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of histamine in the immune response].
    Martínez Filartiga MT
    Alergia; 1985; 32(4):89-103. PubMed ID: 2421597
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical nature of the interaction between macrophage fusion factor and macrophage membranes.
    Rodríguez Acosta FA; Galindo B; Cesàri IM
    Scand J Immunol; 1983 Nov; 18(5):407-10. PubMed ID: 6359371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells.
    Dvorak AM; Dvorak HF; Peters SP; Shulman ES; MacGlashan DW; Pyne K; Harvey VS; Galli SJ; Lichtenstein LM
    J Immunol; 1983 Dec; 131(6):2965-76. PubMed ID: 6315820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding characteristics of fluoresceinated Lotus tetragonolobus fucolectin to macrophage populations which are either responsive or refractory to activation by lymphokine.
    Leu RW; Herriott MJ; Webb CF
    Immunobiology; 1985 Apr; 169(3):272-9. PubMed ID: 3888826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.